stoxline Quote Chart Rank Option Currency Glossary
  
Luminex Corporation (LMNX)
36.99  0 (0%)    12-31 19:00
Open: 37
High: 37
Volume: 1,017,936
  
Pre. Close: 36.99
Low: 36.98
Market Cap: 0(M)
Technical analysis
Short term     
Mid term     
Targets 6-month :  1-year : 
Resists First :  Second : 
Pivot price
Supports First :  Second : 
MAs MA(5) :  MA(20) : 
MA(100) :  MA(250) : 
MACD MACD :  Signal : 
%K %D K(14,3) :  D(3) : 
RSI RSI(14):
52-week High :  Low : 
Price, MAs and Bollinger Bands


Stock Price Prediction
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -
Company Description

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Headline News

Mon, 08 Feb 2021
Luminex Corporation Reports Fourth Quarter and Full-Year 2020 Results - PR Newswire

Wed, 01 Jul 2020
Luminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research Partners - BioSpace

Mon, 01 Jul 2019
Luminex Submits ARIES MRSA Assay for FDA Clearance - PR Newswire

Wed, 02 Jan 2019
Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio - PR Newswire

Mon, 05 Jun 2017
Luminex's VERIGENE Gram-Positive And Gram-Negative Blood Culture Panels Receive Reimbursement Approval In Japan - BioSpace

Fri, 12 Aug 2016
Luminex (LMNX) Stock Price, News & Analysis - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders (%)
Held by Institutions (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin %
Operating Margin %
Return on Assets (ttm) %
Return on Equity (ttm) %
Qtrly Rev. Growth %
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow
Stock Dividends
Dividend
Forward Dividend
Dividend Yield 0%
Dividend Pay Date
Ex-Dividend Date

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android